MIR22HG and osteosarcoma: Furthermore, it can be concluded that the effects of MIR22HG on osteosarcoma cells are achieved by targeting miR-629-5p, which further completes the discoveries on the roles of both MIR22HG and miR-629-5p in osteosarcoma.